WARRANT EXERCISE AND OMNIBUS AMENDMENT AGREEMENTWarrant Exercise and Omnibus Amendment Agreement • August 4th, 2020 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
This Warrant Exercise and Omnibus Amendment Agreement (this “Agreement”), dated as of August 3, 2020, is by and between Sonnet BioTherapeutics Holdings, Inc. a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
